72
edits
Changes
no edit summary
* More information you'll find in the summary of product characteristics (SPC) of aripiprazole depot injection. <ref>https://www.ema.europa.eu/en/medicines/human/EPAR/abilify-maintena SPC of the European Medicines Agency on aripiprazole depot</ref>
* Aripiprazol Abilify Maintena is a prolonged release suspension for injection and is available in 300mg and 400mg and 960mg preparations. It is possible to administer (once a reduced dosage of 300mg month) and 720mg respectivelyand 960mg (once every two months).